adamantane has been researched along with Angiogenesis, Pathologic in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, X; Chen, Y; Hai, W; Lu, S; Peng, J; Shi, S; Xu, Y; Yu, Q; Zhang, M | 1 |
| Ban, HS; Harmalkar, D; Hwang, GS; Kim, BK; Kim, HM; Kim, I; Lee, H; Lee, K; Nam, M; Park, JT; Park, SK; Won, M | 1 |
| Bhattarai, D; Jung, HJ; Kim, BS; Kwon, HJ; Lee, K | 1 |
| Gandin, V; Giorgetti, M; Marzano, C; Porchia, M; Tisato, F; Trenti, A; Trevisi, L; Zanusso, I | 1 |
| Joksović, MD; Jovanović, LS; Leovac, VM; Marković, V; Matić, IZ; Rodić, MV; Spasojević, V; Stanojković, T; Vojinović-Ješić, LS | 1 |
| Anderson, KC; Cartron, MA; Chauhan, D; Grabher, C; Hideshima, T; Lababidi, S; Podar, K; Raab, MS; Sattler, M; Tai, YT; Tonon, G; Vallet, S; Zhang, J; Zhou, Y; Zimmerhackl, A | 1 |
6 other study(ies) available for adamantane and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Multi-functional self-assembled nanoparticles for pVEGF-shRNA loading and anti-tumor targeted therapy.
Topics: A549 Cells; Adamantane; Animals; DNA; Female; Gene Silencing; Humans; Mice, Nude; Molecular Targeted Therapy; Nanoparticles; Neoplasms; Neovascularization, Pathologic; Peptides; Plasmids; Polymers; RNA, Small Interfering; Tumor Burden; Vascular Endothelial Growth Factor A | 2020 |
The novel hypoxia-inducible factor-1α inhibitor IDF-11774 regulates cancer metabolism, thereby suppressing tumor growth.
Topics: Adamantane; Animals; Antineoplastic Agents; Cell Proliferation; Colorectal Neoplasms; Cyclic AMP; Female; Gene Expression Regulation, Neoplastic; Glucose; Glycolysis; HCT116 Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lactic Acid; Mice; Mice, Nude; NAD; Neovascularization, Pathologic; Piperazines; Proto-Oncogene Proteins p21(ras); PTEN Phosphohydrolase; Signal Transduction; TOR Serine-Threonine Kinases; Von Hippel-Lindau Tumor Suppressor Protein; Xenograft Model Antitumor Assays | 2017 |
HIF-1α suppressing small molecule, LW6, inhibits cancer cell growth by binding to calcineurin b homologous protein 1.
Topics: Acetanilides; Adamantane; Amino Acid Sequence; Angiogenesis Inhibitors; Calcium; Calcium-Binding Proteins; Cell Surface Display Techniques; Click Chemistry; Gene Knockdown Techniques; Hep G2 Cells; Human Umbilical Vein Endothelial Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Molecular Docking Simulation; Molecular Sequence Data; Molecular Targeted Therapy; Neovascularization, Pathologic | 2015 |
Homoleptic phosphino copper(I) complexes with in vitro and in vivo dual cytotoxic and anti-angiogenic activity.
Topics: Adamantane; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Body Weight; Cell Line, Tumor; Cell Proliferation; Coordination Complexes; Copper; Female; Human Umbilical Vein Endothelial Cells; Humans; Male; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Organophosphorus Compounds; Phosphines | 2015 |
Synthesis, characterization, cytotoxicity and antiangiogenic activity of copper(II) complexes with 1-adamantoyl hydrazone bearing pyridine rings.
Topics: Adamantane; Angiogenesis Inhibitors; Antineoplastic Agents; Cell Proliferation; Cell Survival; Copper; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Hydrazones; Molecular Structure; Neovascularization, Pathologic; Organometallic Compounds; Pyridines; Structure-Activity Relationship; Tumor Cells, Cultured | 2016 |
Targeting angiogenesis via a c-Myc/hypoxia-inducible factor-1alpha-dependent pathway in multiple myeloma.
Topics: Adamantane; Angiogenesis Inhibitors; Animals; Blotting, Western; Cell Line, Tumor; Down-Regulation; Enzyme-Linked Immunosorbent Assay; Humans; Hydroquinones; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Mice; Mice, Nude; Multiple Myeloma; Neovascularization, Pathologic; Proto-Oncogene Proteins c-myc; Vascular Endothelial Growth Factor A | 2009 |